SCHEMBL23977878

SCHEMBL23977878

Cc1cccc(OCC(F)(F)F)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
G6PD P11413 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDE2A O00408 1/20 0.39
PDE10A Q9Y233 1/20 0.39
UGCG Q16739 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.35
RXRA P19793 1/20 0.35
GRIN1 Q05586 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19563032 0.83 HTR1B (0.51) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL4523648 0.82 ALDH1A1 (0.47) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL8570866 0.81 PTPN1 (0.41) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL28697944 0.81 L3MBTL1 (0.42) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL23977882 0.80 HSP90AA1 (0.39) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL5376369 0.80 MAPT (0.47) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL23977889 0.79 SMN1; SMN2 (0.39) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL19541455 0.79 HTR1B (0.38) ALDH1A1KDM4EMAPTL3MBTL1HTR1B
SCHEMBL256772 0.79 L3MBTL1 (0.47) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL13696491 0.78 MAPT (0.40) ALDH1A1KDM4EMEN1USP2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024020164-A2 GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF FIREFLY BIO, INC. (US) 2024-01-25 WO disclosed
US-20230136562-A1 SPIROUREA DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2023-05-04 US disclosed
WO-2021219594-A1 SPIROUREA DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230136562-A1 SPIROUREA DERIVATIVES KCNA7, PKD2, KCNN3 ALDH1A1 958/4885KDM4E 2078/4885MEN1 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.